| Randomized assessment of rapid endovascular treatment of ischemic stroke M Goyal, AM Demchuk, BK Menon, M Eesa, JL Rempel, J Thornton, ... New England Journal of Medicine 372 (11), 1019-1030, 2015 | 4363 | 2015 |
| Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration JM Wardlaw, EE Smith, GJ Biessels, C Cordonnier, F Fazekas, R Frayne, ... The Lancet Neurology 12 (8), 822-838, 2013 | 2564* | 2013 |
| Variants conferring risk of atrial fibrillation on chromosome 4q25 DF Gudbjartsson, DO Arnar, A Helgadottir, S Gretarsdottir, H Holm, ... Nature 448 (7151), 353-357, 2007 | 898 | 2007 |
| Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke JL Saver, GC Fonarow, EE Smith, MJ Reeves, MV Grau-Sepulveda, ... Jama 309 (23), 2480-2488, 2013 | 712 | 2013 |
| Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association DT Lackland, EJ Roccella, AF Deutsch, M Fornage, MG George, ... Stroke 45 (1), 315-353, 2014 | 640* | 2014 |
| Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times … GC Fonarow, EE Smith, JL Saver, MJ Reeves, DL Bhatt, ... circulation 123 (7), 750-758, 2011 | 611 | 2011 |
| Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage SM Greenberg, JA Eng, MM Ning, EE Smith, J Rosand Stroke 35 (6), 1415-1420, 2004 | 541 | 2004 |
| CLINICAL PERSPECTIVE LH Schwamm, GC Fonarow, MJ Reeves, W Pan, MR Frankel, EE Smith, ... Circulation 119 (1), 107-115, 2009 | 534 | 2009 |
| Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American … BM Demaerschalk, DO Kleindorfer, OM Adeoye, AM Demchuk, JE Fugate, ... Stroke 47 (2), 581-641, 2016 | 507* | 2016 |
| Imaging of amyloid burden and distribution in cerebral amyloid angiopathy KA Johnson, M Gregas, JA Becker, C Kinnecom, DH Salat, EK Moran, ... Annals of Neurology: Official Journal of the American Neurological …, 2007 | 483 | 2007 |
| Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative GC Fonarow, X Zhao, EE Smith, JL Saver, MJ Reeves, DL Bhatt, Y Xian, ... Jama 311 (16), 1632-1640, 2014 | 474 | 2014 |
| 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American Heart Association … KA Hicks, JE Tcheng, B Bozkurt, BR Chaitman, DE Cutlip, A Farb, ... Circulation 132 (4), 302-361, 2015 | 463 | 2015 |
| A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System H Ay, T Benner, E Murat Arsava, KL Furie, AB Singhal, MB Jensen, ... Stroke 38 (11), 2979-2984, 2007 | 444 | 2007 |
| MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength RNK Nandigam, A Viswanathan, P Delgado, ME Skehan, EE Smith, ... American Journal of Neuroradiology 30 (2), 338-343, 2009 | 433 | 2009 |
| Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score NS Rost, EE Smith, Y Chang, RW Snider, R Chanderraj, K Schwab, ... Stroke 39 (8), 2304-2309, 2008 | 408 | 2008 |
| Cerebral microinfarcts: the invisible lesions EE Smith, JA Schneider, JM Wardlaw, SM Greenberg The Lancet Neurology 11 (3), 272-282, 2012 | 387 | 2012 |
| Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates JD Schmahmann, EE Smith, FS Eichler, CM Filley Annals of the New York Academy of Sciences 1142, 266, 2008 | 363 | 2008 |
| Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes D Dowlatshahi, AM Demchuk, ML Flaherty, M Ali, PL Lyden, EE Smith Neurology 76 (14), 1238-1244, 2011 | 352 | 2011 |
| Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy ME Gurol, MC Irizarry, EE Smith, S Raju, R Diaz-Arrastia, T Bottiglieri, ... Neurology 66 (1), 23-29, 2006 | 341 | 2006 |
| Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative GC Fonarow, EE Smith, JL Saver, MJ Reeves, AF Hernandez, ... Stroke 42 (10), 2983-2989, 2011 | 339 | 2011 |
Lee SchwammProfessor of Neurology, Harvard Medical SchoolVerified email at mgh.harvard.edu
